tiprankstipranks
GlaxoSmithKline (GB:GSK)
LSE:GSK
UK Market
GSK
GlaxoSmithKline
RESEARCH TOOLSreports
Want to see GB:GSK full AI Analyst Report?

GlaxoSmithKline (GSK) Ratios

1,150 Followers

GlaxoSmithKline Ratios

GB:GSK's free cash flow for Q1 2026 was £0.75. For the 2026 fiscal year, GB:GSK's free cash flow was decreased by £ and operating cash flow was £0.30. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.79 0.82 0.78 0.88 0.91
Quick Ratio
 0.52 0.54 0.52 0.62 0.68
Cash Ratio
 0.15 0.15 0.17 0.14 0.16
Solvency Ratio
 0.20 0.21 0.11 0.16 0.34
Operating Cash Flow Ratio
 0.34 0.34 0.30 0.32 0.32
Short-Term Operating Cash Flow Coverage
 1.50 2.54 3.01 2.55 1.96
Net Current Asset Value
£ -27.69B£ -27.65B£ -29.38B£ -27.57B£ -29.28B
Leverage Ratios
Debt-to-Assets Ratio
 0.30 0.29 0.29 0.31 0.35
Debt-to-Equity Ratio
 1.07 1.08 1.24 1.35 1.98
Debt-to-Capital Ratio
 0.52 0.52 0.55 0.57 0.66
Long-Term Debt-to-Capital Ratio
 0.44 0.46 0.50 0.51 0.60
Financial Leverage Ratio
 3.52 3.73 4.35 4.42 5.68
Debt Service Coverage Ratio
 1.82 3.01 2.18 2.44 1.71
Interest Coverage Ratio
 10.37 10.23 8.79 9.02 7.84
Debt to Market Cap
 0.26 0.23 0.29 0.29 0.35
Interest Debt Per Share
 4.91 4.55 4.32 4.64 5.42
Net Debt to EBITDA
 1.35 1.23 1.99 1.65 2.00
Profitability Margins
Gross Profit Margin
72.74%72.54%69.80%70.07%66.37%
EBIT Margin
24.86%24.81%13.14%22.57%22.10%
EBITDA Margin
35.28%36.38%21.27%30.13%29.43%
Operating Profit Margin
22.34%21.95%18.05%23.06%22.79%
Pretax Profit Margin
22.69%22.66%11.08%19.99%19.19%
Net Profit Margin
17.78%17.50%8.21%16.25%51.00%
Continuous Operations Profit Margin
19.39%19.25%9.41%17.50%16.78%
Net Income Per EBT
78.38%77.23%74.06%81.27%265.74%
EBT Per EBIT
101.56%103.24%61.41%86.72%84.23%
Return on Assets (ROA)
9.27%9.35%4.33%8.35%24.87%
Return on Equity (ROE)
35.78%34.90%18.84%36.92%141.12%
Return on Capital Employed (ROCE)
18.11%18.05%14.99%18.43%17.90%
Return on Invested Capital (ROIC)
13.76%14.25%11.98%15.02%14.15%
Return on Tangible Assets
15.57%15.30%6.97%13.17%38.56%
Earnings Yield
7.86%7.73%4.69%8.39%25.84%
Efficiency Ratios
Receivables Turnover
 4.23 4.97 5.23 5.14 4.72
Payables Turnover
 0.62 2.54 2.74 2.44 2.55
Inventory Turnover
 1.45 1.51 1.67 1.65 1.92
Fixed Asset Turnover
 3.27 3.25 3.11 3.05 3.05
Asset Turnover
 0.52 0.53 0.53 0.51 0.49
Working Capital Turnover Ratio
 -7.67 -7.61 -8.81 -13.58 -8.33
Cash Conversion Cycle
 -247.64 170.69 154.80 142.69 124.77
Days of Sales Outstanding
 86.36 73.46 69.79 71.07 77.40
Days of Inventory Outstanding
 251.46 241.08 218.36 221.11 190.46
Days of Payables Outstanding
 585.46 143.86 133.35 149.48 143.08
Operating Cycle
 337.82 314.55 288.15 292.17 267.85
Cash Flow Ratios
Operating Cash Flow Per Share
 1.88 1.80 1.61 1.67 1.84
Free Cash Flow Per Share
 1.25 1.47 0.88 1.09 1.28
CapEx Per Share
 0.63 0.33 0.73 0.58 0.56
Free Cash Flow to Operating Cash Flow
 0.67 0.82 0.55 0.65 0.69
Dividend Paid and CapEx Coverage Ratio
 1.47 1.87 1.21 1.47 1.29
Capital Expenditure Coverage Ratio
 2.99 5.42 2.20 2.89 3.28
Operating Cash Flow Coverage Ratio
 0.40 0.41 0.39 0.38 0.35
Operating Cash Flow to Sales Ratio
 0.23 0.22 0.21 0.22 0.25
Free Cash Flow Yield
6.82%8.06%6.51%7.53%8.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.72 12.93 21.32 11.92 3.87
Price-to-Sales (P/S) Ratio
 2.24 2.26 1.75 1.94 1.97
Price-to-Book (P/B) Ratio
 4.15 4.51 4.02 4.40 5.46
Price-to-Free Cash Flow (P/FCF) Ratio
 14.65 12.41 15.37 13.28 11.25
Price-to-Operating Cash Flow Ratio
 9.82 10.12 8.38 8.68 7.82
Price-to-Earnings Growth (PEG) Ratio
 0.14 0.10 -0.44 -0.18 0.02
Price-to-Fair Value
 4.15 4.51 4.02 4.40 5.46
Enterprise Value Multiple
 7.71 7.45 10.22 8.08 8.71
Enterprise Value
 89.19B 88.48B 68.19B 73.84B 75.14B
EV to EBITDA
 7.71 7.45 10.22 8.08 8.71
EV to Sales
 2.72 2.71 2.17 2.43 2.56
EV to Free Cash Flow
 17.76 14.86 19.09 16.69 14.60
EV to Operating Cash Flow
 11.81 12.12 10.40 10.91 10.15
Tangible Book Value Per Share
 -1.99 -1.93 -2.31 -2.17 -2.80
Shareholders’ Equity Per Share
 4.44 4.04 3.35 3.29 2.63
Tax and Other Ratios
Effective Tax Rate
 0.15 0.15 0.15 0.12 0.13
Revenue Per Share
 8.15 8.06 7.70 7.48 7.28
Net Income Per Share
 1.45 1.41 0.63 1.22 3.71
Tax Burden
 0.78 0.77 0.74 0.81 2.66
Interest Burden
 0.91 0.91 0.84 0.89 0.87
Research & Development to Revenue
 0.23 0.23 0.18 0.17 0.16
SG&A to Revenue
 0.28 0.28 0.34 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.01 0.01 0.01
Income Quality
 1.20 1.28 2.22 1.37 1.50
Currency in GBP